Latest News about JNJ
Recent news which mentions JNJ
Why BioNTech Thrashed the Market on Thursday
September 23, 2021
From Motley Fool
10 Oversold Stocks to Buy for the Final Quarter
September 23, 2021
From InvestorPlace
7 High-Yield Dividend Stocks That Will Please Any Income Lover
September 23, 2021
From InvestorPlace
7 Robinhood Stocks to Buy for Newbie Investors
September 23, 2021
From InvestorPlace
3 Relatively Safe Pharma Stocks You Can Buy Right Now
September 23, 2021
From Motley Fool
Why Moderna Stock Is Rising Today
September 22, 2021
From Motley Fool
Is Ketamine A Psychedelic? Depends On Who You Ask
September 22, 2021
From Benzinga
These 2 Dividend ETFs Are a Retiree's Best Friend
September 22, 2021
From Motley Fool
After Today's Fed Meeting, Investors Are Stuck With Contradictory Reports On Evergrande And The Debt Ceiling
September 22, 2021
From Benzinga
Got $5,000? Buy and Hold These 3 Value Stocks for Years
September 22, 2021
From Motley Fool
Moderna's COVID Vaccine Could Be Better Than Pfizer's -- Here's Why Its Stock Isn't
September 22, 2021
From Motley Fool
Boosters And Mandate Could Increase Vaccine Demand
September 21, 2021
From Benzinga
7 Stocks to Buy Following Vaccine Victories
September 21, 2021
From InvestorPlace
FDA To Probably Decide On Pfizer/BioNTech COVID-19 Booster Shots By Tomorrow: Bloomberg
September 21, 2021
From Benzinga
J&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decision
September 21, 2021
From MarketWatch
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
3 Underrated Warren Buffett Stocks That Are Smart Buys Right Now
September 21, 2021
From Motley Fool
JPMorgan says buy that S&P 500 dip, but you might want to look at this chart first
September 21, 2021
From MarketWatch
Why Protagonist Therapeutics Stock Plunged Today
September 20, 2021
From Motley Fool
Here are the worst-performing U.S. stocks as the Evergrande crisis rattles investors
September 20, 2021
From MarketWatch
Positive results in COVID-19 vaccine trial of 5-to-11-year-olds tempered as U.S. daily death rate tops 2,000 for first time since March 1
September 20, 2021
From MarketWatch
It’s OK to Sell the News on Ocugen and Covaxin
September 20, 2021
From InvestorPlace
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
From Benzinga
Got $1,000? Here Are 2 Unstoppable Dividend Stocks to Buy
September 19, 2021
From Motley Fool
Here's Why Moderna's Stock Could Crash Before the End of 2021
September 19, 2021
From Motley Fool
Moderna's Bigger Catalyst: Full FDA Approval or Booster Authorization?
September 19, 2021
From Motley Fool
Could This News Spark a Turnaround for Ocugen?
September 19, 2021
From Motley Fool
FDA committee votes against approving BioNTech and Pfizer’s COVID-19 booster
September 17, 2021
From MarketWatch
3 Value Dividend Stocks for High Total Returns
September 17, 2021
From InvestorPlace
Janssen Shares Erdafitinib Combo Therapy Data In Bladder Cancer
September 17, 2021
Tickers
JNJ
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.